Trends in Pharmacological Sciences 1995 - Abstracts
| Trends in Pharmacological Sciences 1995 | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| 3D-QSAR: a current perspective. (three-dimensional quantitative structure-activity relationship paradigms) | Pharmaceuticals and cosmetics industries | Green, Stuart M., Marshall, Garland R. | |||
| Adenosine, antioxidant enzymes and cytoprotection. | Pharmaceuticals and cosmetics industries | Maggirwar, Sanjay B., Ramkumar, Vickram, Nie, Zhongzhen, Ryback, Leonard P. | |||
| A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. (adenosine diphosphate) | Pharmaceuticals and cosmetics industries | Leff, Paul, Humphries, Robert G., Robertson, Mark J. | |||
| Cloning of human prostanoid receptors. | Pharmaceuticals and cosmetics industries | Gil, Daniel W., Pierce, Kristen L., Woodward, David F., Regan, John W. | |||
| Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency. | Pharmaceuticals and cosmetics industries | Gonzalez, Frank J., Fernandez-Salguero, Pedro | |||
| Endogenous ligands and inverse agonism. | Pharmaceuticals and cosmetics industries | Baxter, Gordon S., Tilford, Nick S. | |||
| Endothelin: a knockout in London. (4th International Conference on Endothelin) | Pharmaceuticals and cosmetics industries | Warner, Timothy D., Battistini, Bruno, Botting, Renia | |||
| Experimental headache models in animals and humans. | Pharmaceuticals and cosmetics industries | Edvinsson, Lars | |||
| Fast electrochemical studies in isolated tissues. | Pharmaceuticals and cosmetics industries | Kruk, ZygmuntL., O'Connor, John J. | |||
| Inverse agonism: pharmacological curiosity or potential therapeutic strategy? | Pharmaceuticals and cosmetics industries | Milligan, Graeme, Bond, Richard A., Lee, Melanie | |||
| Na+ in cystic fibrosis: is it important? | Pharmaceuticals and cosmetics industries | Knox, Alan, Peckham, Daniel | |||
| P2 purinoceptor-mediated second messenger responses. | Pharmaceuticals and cosmetics industries | ||||
| PET: a symposium highlighting its clinical and pharmacological potential. (positron emission tomography) | Pharmaceuticals and cosmetics industries | Ritter, James M., Jones, Terry | |||
| Pharmacological inhibition of restenosis: learning from experience. | Pharmaceuticals and cosmetics industries | Rudin, Markus, Shaw, Linda A., Cook, Nigel S. | |||
| Pharmacological proteus? (receptor properties of ligands) | Pharmaceuticals and cosmetics industries | Kenakin, Terry | |||
| Recent advances in the pharmacology of Ca2+ and K+ channels. | Pharmaceuticals and cosmetics industries | Godfraind, Theophile, Govoni, Stefano | |||
| The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function. | Pharmaceuticals and cosmetics industries | Strosberg, A. Donny, Nahmias, Clara | |||
| The European Medicines Evaluation Agency: role of experts in drug assessment. (includes related article) | Pharmaceuticals and cosmetics industries | Benzi, Gianni | |||
| The IUPHAR teaching site on the World Wide Web. (International Union of Pharamacology) | Pharmaceuticals and cosmetics industries | Jarrott, Bevyn, Williams, Darren | |||
| TiPS on nomenclature. (receptors) | Pharmaceuticals and cosmetics industries | Watson, Steve, Girdlestone, Debbie | |||
| Use of the elevated plus maze in the search for novel anxiolytic agents. (includes related article) | Pharmaceuticals and cosmetics industries | Dawson, Gerard R., Tricklebank, Mark D. | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.